Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Atreca
500 Saginaw Drive
Redwood City, CA 94063
Phone: 650-595-2595
http://www.atreca.com/

Atreca is a privately held biotechnology company developing novel therapeutics drawn from human immune responses, including effective anti-cancer immune responses. We are able to measure and analyze the structure of clinically relevant immune responses to identify the antibodies, T cell receptors, and targets that are key to successful treatment outcomes. Atreca's proprietary Immune Repertoire Capture technology profiles a patient's immune response at the single-cell level at very high throughput essentially without bias or error, enabling the identification and generation of functional human antibodies and TCRs without prior knowledge of antigen.

Key Contact
Name
Tito A Serafini, PhD
Title
President & CEO
Funding Events

Date
Amount
Type
Investors
08/17/17 $35,000,000 Series B Cormorant Asset Management
Wellington Management Company
09/13/18 $125,000,000 Series C Aisling Capital
Boxer Capital
Cormorant Asset Management
EcoR1 Capital
Redmile Group
Samsara BioCapital
Tavistock Group
Tekla Capital Management
Wellington Management Company


Featured Reading